Fulyzaq | search
Click here to view Fulyzaq news from 60+ newspapers.
Bookmark or Share- Crofelemer Uses, Side Effects & Warnings - Drugs.comBrand names: Mytesi, Fulyzaq Dosage form: oral delayed release tablet (125 mg) Drug class: Antidiarrheals. Medically reviewed by Drugs.com on Mar 21, 2024. Written by Cerner Multum. Uses; Side effects; Warnings; Before taking; Dosage; Interactions
- FULYZAQ (crofelemer) label - Food and Drug AdministrationFULYZAQ is an anti-diarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy (1) -----------------DOSAGE AND...
- Crofelemer: Uses, Interactions, Mechanism of Action - DrugBankCrofelemer is an inhibitor of the cystic fibrosis transmembrane regulator chloride channel (CFTR), as evidenced by its activity on cell cultures, single cell patch clamps, single CFTR channels, and elaboration of mouse intestinal fluid secretion.
- 202292Orig1s000This submission, received December 5, 2011, is the initial New Drug Application (NDA) for Fulyzaq® (crofelemer), a polymeric proanthocyanidin extracted from the red latex sap of the plant species...
- Fulyzaq (Crofelemer) Oral: Uses, Dosage & Side Effects - FindaTopDocFulyzaq, an anti-diarrheal medication, is used to for the symptomatic relief of non-infectious diarrhea in adult HIV/AIDS patients, who are taking anti-retroviral medications. It is only available with a prescription. It comes in delayed-release tablet form.
More
